Literature DB >> 24327984

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Mi-La Kim1, Seok Ju Seong.   

Abstract

The levonorgestrel-releasing intrauterine system (LNG-IUS), originally designed for contraception, has since been applied to various gynecologic diseases. This article summarizes the current status of clinical applications of LNG-IUS to the treatment of gynecologic diseases such as heavy menstrual bleeding, endometriosis, leiomyoma, adenomyosis, endometrial hyperplasia, and early-stage endometrial cancer.

Entities:  

Keywords:  Adenomyosis; Endometrial cancer; Endometrial hyperplasia; Endometriosis; Leiomyoma; Levonorgestrel-releasing intrauterine system; Menorrhagia

Year:  2013        PMID： 24327984      PMCID： PMC3784091          DOI： 10.5468/OGS.2013.56.2.67

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN： 2287-8572


  92 in total

1.  Advances in the management of endometrial carcinoma.

Authors:  Mario M Leitao; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2011-01-07       Impact factor: 5.482

Review 2.  Intrauterine devices and intrauterine systems.

Authors: 
Journal:  Hum Reprod Update       Date:  2008-04-09       Impact factor: 15.610

3.  The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.

Authors:  F Mercorio; R De Simone; A Di Spiezio Sardo; G Cerrota; G Bifulco; F Vanacore; C Nappi
Journal:  Contraception       Date:  2003-04       Impact factor: 3.375

Review 4.  The levonorgestrel intrauterine system: therapeutic aspects.

Authors:  T Luukkainen
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

5.  Progestogen treatment options for early endometrial cancer.

Authors:  T J Cade; M A Quinn; R M Rome; D Neesham
Journal:  BJOG       Date:  2010-04-12       Impact factor: 6.531

6.  Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report.

Authors:  J R Nelson; S L Corson
Journal:  Fertil Steril       Date:  1993-02       Impact factor: 7.329

7.  Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel.

Authors:  R Hurskainen; A Salmi; J Paavonen; J Teperi; E Rutanen
Journal:  Mol Hum Reprod       Date:  2000-11       Impact factor: 4.025

8.  Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).

Authors:  Mi Kyoung Kim; Seok Ju Seong; Taek Sang Lee; Jae Weon Kim; Byung Ho Nam; Sung Ran Hong; Kwang Sun Suh
Journal:  Jpn J Clin Oncol       Date:  2012-10-15       Impact factor: 3.019

9.  Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial.

Authors:  F Parazzini; L Fedele; M Busacca; L Falsetti; S Pellegrini; P L Venturini; M Stella
Journal:  Am J Obstet Gynecol       Date:  1994-11       Impact factor: 8.661

10.  The prevalence of endometriosis in premenopausal women undergoing gynecological surgery.

Authors:  S Ajossa; V Mais; S Guerriero; A M Paoletti; A Caffiero; C Murgia; G B Melis
Journal:  Clin Exp Obstet Gynecol       Date:  1994       Impact factor: 0.146
View more
  8 in total

Review 1.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.

Authors:  Maria-Eulalia Fernandez-Montoli; Jordi Sabadell; Nayanar-Adela Contreras-Perez
Journal:  Adv Ther       Date:  2021-04-08       Impact factor: 3.845

3.  Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis.

Authors:  Xiufeng Huang; Qiongshi Huang; Shuyi Chen; Jing Zhang; Kaiqing Lin; Xinmei Zhang
Journal:  BMC Womens Health       Date:  2015-03-13       Impact factor: 2.809

4.  Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management.

Authors:  Oroma Nwanodi
Journal:  Healthcare (Basel)       Date:  2017-07-08

Review 5.  Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.

Authors:  Nayanar-Adela Contreras; Jordi Sabadell; Paula Verdaguer; Carla Julià; Maria-Eulalia Fernández-Montolí
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 6.  Adenomyosis and its impact on women fertility.

Authors:  Elisabetta Garavaglia; Serafini Audrey; Inversetti Annalisa; Ferrari Stefano; Tandoi Iacopo; Corti Laura; Candiani Massimo
Journal:  Iran J Reprod Med       Date:  2015-06

7.  Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.

Authors:  Da Hee Kim; Seok Ju Seong; Mi Kyoung Kim; Hyo Sook Bae; Mi La Kim; Bo Seong Yun; Yong Wook Jung; Jeong Yun Shim
Journal:  J Gynecol Oncol       Date:  2016-08-02       Impact factor: 4.401

8.  Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps.

Authors:  Fangfang Li; Shuangyan Wei; Shuye Yang; Zhiqiang Liu; Fangfang Nan
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.